<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945083</url>
  </required_header>
  <id_info>
    <org_study_id>BL55</org_study_id>
    <nct_id>NCT04945083</nct_id>
  </id_info>
  <brief_title>Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition</brief_title>
  <official_title>Gastrointestinal Tolerance and Acceptability of a High Protein, High Calorie Pudding in Adult Patients With/or at Risk for Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, prospective, non-randomized, non-blinded, single-arm, single&#xD;
      treatment study to evaluate the tolerance of a nutritional pudding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 13, 2021</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastro-Intestinal Tolerance</measure>
    <time_frame>Study Day 1 to Study Day 8</time_frame>
    <description>Subject completed Bristol Stool Type questionnaire; Stool is classified into 7 groups (Types 1-7) with Type 3-4 as ideal stools</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional Supplement Palatability</measure>
    <time_frame>Study Day 1 to Study Day 8</time_frame>
    <description>Subject completed questionnaire; 4 questions scaled from 1 -Dislike Extremely to 9-Like Extremely; 2 questions scaled from Not at all Enough to Far Too</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional Supplement Compliance</measure>
    <time_frame>Study Day 1 to Study Day 28</time_frame>
    <description>Subject completed daily intake questionnaire including amount of serving consumed</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline to Study Day 28</time_frame>
    <description>For BMI Calculation</description>
  </other_outcome>
  <other_outcome>
    <measure>Height</measure>
    <time_frame>Baseline to Study Day 28</time_frame>
    <description>For BMI Calculation</description>
  </other_outcome>
  <other_outcome>
    <measure>Medication Usage</measure>
    <time_frame>Baseline to Study Day 28</time_frame>
    <description>Subject reported medication usage</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Baseline to Study Day 28</time_frame>
    <description>Subject reported adverse events</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Gastrointestinal Tolerance</condition>
  <arm_group>
    <arm_group_label>Experimental Nutritional Pudding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 servings per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Nutritional Pudding</intervention_name>
    <description>High Calorie, High Protein pudding</description>
    <arm_group_label>Experimental Nutritional Pudding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has voluntarily signed and dated an ICF approved by an IEC, and provided&#xD;
             applicable privacy authorization prior to any participation&#xD;
&#xD;
          -  Subject is considered by a dietitian or clinician as malnourished or at risk for&#xD;
             malnutrition based on current use of an oral nutritional supplement (ONS), recently&#xD;
             identified as malnourished or at risk of malnutrition based on validated malnutrition&#xD;
             screening tool or has had weight loss within last two months as a result of a&#xD;
             hospitalization or chronic illness&#xD;
&#xD;
          -  Subject currently has normal GI function&#xD;
&#xD;
          -  Subject requires ONS and is willing to comply with the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has severe dementia or delirium, eating disorder, history of significant&#xD;
             neurological or psychiatric disorder affecting abilities to answer questions,&#xD;
             alcoholism, substance abuse or other conditions that may interfere with study product&#xD;
             consumption or compliance with study protocol procedures&#xD;
&#xD;
          -  Subject had a history of diabetes as evidenced by taking antihyperglycemic medications&#xD;
             or by self-reported dietary modification&#xD;
&#xD;
          -  Subject is currently taking or has taken antibiotics within 1 week prior to enrollment&#xD;
&#xD;
          -  Subject has undergone major GI surgery less than 3 months prior to enrollment in the&#xD;
             study&#xD;
&#xD;
          -  Subject has current active malignant disease or was treated within the last 6 months&#xD;
             for cancer, except basal or squamous cell skin carcinoma, prior to enrollment&#xD;
&#xD;
          -  Subject has an immunodeficiency disorder&#xD;
&#xD;
          -  Subject has had a myocardial infarction within the last 3 months prior to enrollment&#xD;
&#xD;
          -  Subject is known to be allergic or intolerant to any ingredient found in the study&#xD;
             product&#xD;
&#xD;
          -  Subject has an aversion to any of the flavours of product being tested&#xD;
&#xD;
          -  Subject has an obstruction of the GI tract precluding ingestion or absorption of the&#xD;
             study product, inflammatory bowel disease, gastric esophageal reflux disease, short&#xD;
             bowel syndrome, or other major gastrointestinal disease-causing symptoms including&#xD;
             (but not limited to) uncontrollable severe diarrhea, nausea, or vomiting&#xD;
&#xD;
          -  Subject is currently taking medications/dietary supplements/substances that could&#xD;
             profoundly modulate metabolism or affect gastrointestinal motility&#xD;
&#xD;
          -  Participation in another study that has not been approved as a concomitant study&#xD;
&#xD;
          -  Subject has a clinical condition that is contraindicated with this product as&#xD;
             determined by the clinician in accordance with standard of care&#xD;
&#xD;
          -  Subject is pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Camprubi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LDN</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Coast Medical Ltd, Newquay Health Centre</name>
      <address>
        <city>Newquay</city>
        <state>Cornwall</state>
        <zip>TR7 1RU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Alverton Practice, Atlantic Medical</name>
      <address>
        <city>Penzance</city>
        <state>Cornwall</state>
        <zip>TR18 3DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Morrab Surgery</name>
      <address>
        <city>Penzance</city>
        <state>Cornwall</state>
        <zip>TR18 4EL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 7, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

